Big pharma, Biotech, Partnering, Pharma

Biogen Idec big pharma deals Adaptive Biotechnologies for immunological biomarkers collaborative R&D

Posted on 28 June 2013

Tags: , , ,

Adaptive Biotechnologies signed pharma deals with Biogen Idec for the study of the immune repertoire and the search for immunological biomarkers in difficult to treat autoimmune diseases.

Under the pharma deals collaboration, Adaptive's proprietary immune profiling assay, immunoSEQ, will be used to characterize the immune repertoire of patient samples with autoimmune disorders with high unmet medical needs.

The immunoSEQ assay uses high throughput next-generation sequencing to characterize the repertoire of T and B cell receptors, which can be very useful to monitor the immune status of patients with autoimmune diseases and to assess the impact of treatments that impact or alter the immune system and will be useful for the current pharma deals.

Adaptive Biotechnologies is pioneering the field of genomic immunology.

The company's core competency is developing next generation sequencing assays that characterize the adaptive immune system, serving as a platform technology to the research and clinical communities as well as the biopharmaceutical industry and this will be utilised in the pharma deals.


Report: Immunology Partnering Terms and Agreements

Report: Infectives Partnering Terms and Agreements

Report: Partnering Deals and Alliances with Biogen Idec

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply